histopathology annotation services
We provide unimpeachable annotation, validation, and QC services for pharmaceutical research and AI model training. Powered by clinical experts, not generic annotators.
6,000+
Clinical Expertise
Hours of Annotation
N+1
Quality Assurance
Consensus Model
100%
Team Structure
Certified Pathologists
Pharma & AI
Applications
Regulatory Ready
Often rely on non-medical staff or students. Prone to inter-observer variability and lack of clinical nuance needed for regulatory submission.
All workflows are supervised by Certified Pathologists. We use a multi-tiered validation system to minimize edge cases and ensure diagnostic accuracy.
In pharmaceutical research and diagnostic AI, the cost of bad data is exponential. We recognize the critical need for ground truth data that stands up to scrutiny.
End-to-end annotation solutions tailored specifically to the complexity required by pharmaceutical and AI domains.
Region-of-Interest marking, Tumor/Stroma segmentation, Lesion identification, and histological feature segmentation for model training.
High-precision single-cell annotation, mitotic figures, nuclear/cytoplasmic contours, and structure-level tagging.
IHC scoring (Ki-67, PD-L1), ISH/FISH spot counting, and H-Score calculation for drug efficacy studies.
Lesion grading (Gleason, Nottingham) and Tumor Microenvironment component annotation (TILs, Fibrosis).
From protocol design to final dataset delivery.
We develop standardized, pathologist-led SOPs ensuring adherence to your study-specific criteria.
Primary Pathologist Annotation followed by Secondary Pathologist QC and Senior Validation.
Final consistency checks and dataset validation, ensuring data is ready for AI/ML ingestion.
We strip away the administrative bloat found in large CROs.
No intermediaries or project management layers. You communicate directly with the medical experts.
Transparent pricing models designed for commercially viable annotation at scale.
High-quality data reduces model retraining costs, making our "Gold Standard" the most economical choice long-term.
Whether you need a pilot study or a large-scale dataset, our team is ready to deliver gold-standard data.